Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI known ✓ | P41743 | 1/20 | 0.51 |
| ▸ | TBXAS1 | P24557 | 14/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | QPCT | Q16769 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28470038 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL29131135 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL17273534 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL4913930 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL22026958 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL25395768 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL2994509 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL4361596 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL22027279 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL28550671 | 1.00 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119318921-A | Carbon nano tube gel, gel electrolyte and preparation method and application thereof | 中国科学院上海应用物理研究所 | 2025-01-17 | — | — | CN | claimed |
| CN-116676622-A | Preparation method and application of atomic-level dispersed single-layer iron phthalocyanine-based catalyst for electrochemical synthesis of ammonia | 浙江工业大学 | 2023-09-01 | — | — | CN | claimed |
| CN-110863106-B | Method for extracting copper ions by ionic liquid through aqueous two-phase extraction | 江南大学 | 2021-07-27 | — | — | CN | claimed |
| CN-110863106-A | Method for extracting copper ions by ionic liquid through aqueous two-phase extraction | 江南大学 | 2020-03-06 | — | — | CN | claimed |
| CN-108949141-A | The preparation method of bistable state electrochromic material and it is used to prepare electrochromic device | 常州铱视光电科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | claimed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| CN-122071545-A | Ultra-high molecular weight polyethylene, preparation method thereof and ultra-high molecular weight polyethylene fiber | 中国石油化工股份有限公司 | 2026-05-22 | — | — | CN | disclosed |
| EP-4148141-B1 | KIT FOR NUCLEIC ACID CAPTURE | ZYMO RES CORPORATION (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250270537-A1 | METHODS FOR NUCLEIC ACID CAPTURE | ZYMO RESEARCH CORPORATION (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250041239-A1 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | ISHA Therapeutics LLC (US) | 2025-02-06 | — | — | US | disclosed |
| CN-119318921-A | Carbon nano tube gel, gel electrolyte and preparation method and application thereof | 中国科学院上海应用物理研究所 | 2025-01-17 | — | — | CN | disclosed |
| US-12109303-B2 | Orally dissolving antimicrobial film compositions and methods of their use | ISHA Therapeutics LLC (US) | 2024-10-08 | — | — | US | disclosed |
| US-20130292255-A1 | ALUMINUM OR ALUMINUM ALLOY MOLTEN SALT ELECTROPLATING BATH HAVING GOOD THROWING POWER, ELECTROPLATING METHOD USING THE BATH, AND PRETREATMENT METHOD OF THE BATH | DIPSOL CHEMICALS CO., LTD (JP) | 2013-11-07 | — | — | US | disclosed |
| EP-2492376-A1 | METHOD OF BARREL ELECTROPLATING WITH ALUMINUM OR ALUMINUM ALLOY | Dipsol Chemicals Co., Ltd. (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20120205249-A1 | Aluminum or Aluminum Alloy Barrel Electroplating Method | HONDA MOTOR CO., LTD. (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20120052324-A1 | Electric Al-Zr-Mn Alloy-Plating Bath Using Room Temperature Molten Salt Bath, Plating Method Using the Same and Al-Zr-Mn Alloy-Plated Film | HONDA MOTOR CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20120031766-A1 | Electric Al or Al Alloy Plating Bath Using Room Temperature Molten Salt Bath and Plating Method Using the Same | HONDA MOTOR CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20100285322-A1 | Electric Al-Zr Alloy Plating Bath Using Room Temperature Molten Salt Bath and Plating Method Using the Same | DIPSOL CHEMICALS CO., LTD. (JP) | 2010-11-11 | — | — | US | disclosed |
| EP-2130949-A1 | ELECTRIC Al-Zr ALLOY PLATING BATH USING ROOM TEMPERATURE MOLTEN SALT BATH AND PLATING METHOD USING THE SAME | Dipsol Chemicals Co., Ltd. (JP) | 2009-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041239-A1 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | RAB5IF, CGAS, APOB | PRKCI 907/4885TBXAS1 2326/4885KDM4E 4812/4885 |
| US-12109303-B2 | Orally dissolving antimicrobial film compositions and methods of their use | RAB5IF, APOB, ERG28 | PRKCI 2140/4885TBXAS1 2069/4885KDM4E 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.